Headquarters:
New York, NY
Description:
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Founders:
Tom Skarpelos
Categories:
Biotechnology
Website:
http://anavex.com

Detailed Description

Update

Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery SIGMACEPTOR™ platform. The Anavex portfolio comprises novel, wholly owned sigma receptor agonists and antagonists. The company’s lead drug candidate for Alzheimer’s Disease (AD), ANAVEX 2-73, has successfully completed a Phase 1 single ascending dose (SAD) clinical trial. The company has also started scale-up manufacturing for ANAVEX 1-41, its second lead compound, targeting depression and AD. With sufficient quantities of ANAVEX 1-41 in hand, the company will be in a position to advance the program and begin preclinical studies on large animals in the near term.

Current Team (2)

Update

Past Team (3)

Update

Funding Rounds (2) - $12.6M

Update

Board Members and Advisors (6)

Update

Offices/Locations (1)

Update
  • Office

    51 West 52nd Street

    7th floor

    New York, NY NY 10019

    USA